Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial
Journal
Annals of internal medicine
Journal Volume
159
Journal Issue
11
Pages
729
Date Issued
2013-12-03
Author(s)
Huang, Chung-Feng
Dai, Chia-Yen
Liang, Cheng-Chao
Huang, Jee-Fu
Hung, Peir-Haur
Chen, Shih-I
Yang, Sheng-Shun
Chuang, Wan-Long
Yu, Ming-Lung
Abstract
Data are limited on the efficacy and safety of pegylated interferon plus ribavirin for patients with hepatitis C virus genotype 1 (HCV-1) receiving hemodialysis.
Subjects
28B GENETIC POLYMORPHISMS; DIALYSIS PATIENTS; PLUS RIBAVIRIN; TREATMENT DURATION; KIDNEY-TRANSPLANTATION; ANTIVIRAL THERAPY; VIRAL KINETICS; HCV PATIENTS; INFECTION; ALPHA-2A
SDGs
Publisher
AMER COLL PHYSICIANS
Type
journal article